Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Securities and Exchange Commission v. liang et al
Case Number:
8:11-cv-00819
Court:
Nature of Suit:
Judge:
Government Agencies
-
November 28, 2011
FDA Chemist Settles Insider Trading Suit For $4M
A U.S. Food and Drug Administration chemist charged with making trades using private information about companies with pending drug applications agreed to pay $3.7 million on Monday to settle the U.S. Securities and Exchange Commission's civil case.
-
June 02, 2011
SEC Widens Insider Trading Case Against FDA Chemist
The U.S. Securities and Exchange Commission on Thursday expanded its insider trading claims against a Food and Drug Administration chemist also facing criminal charges, adding allegations of another illegal stock deal.